Learn / CLYM
NASDAQ: CLYM
Climb Bio (CLYM) stock, explained like you're 5
Climb Bio trades on the Nasdaq under the ticker CLYM. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 632 million dollars.
- Ticker
- CLYM
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 632 million dollars
Is Climb Bio a small, medium or large cap company?
No. Climb Bio is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 632 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Climb Bio makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CLYM stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Climb Bio's Upcoming Data Updates on CLYM116, Budoprutug to Be 'More Incremental,' RBC Says (Yahoo Finance)
- H.C. Wainwright reiterates Climb Bio stock rating ahead of data (Investing.com)
- Climb Bio: Others Proved APRIL Works, So The Bet Is On The 12 Week Dosing Interval (Seeking Alpha)
- $CLYM stock is up 9% today. Here's what we see in our data. (Quiver Quantitative)
- Preliminary data from a kidney disease drug study were selected for an October talk. (Stock Titan)
Follow CLYM in your daily brief
Each trading day at 5 PM ET we post what happened to Climb Bio and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CLYM
Questions about Climb Bio stock
What does Climb Bio do?
Climb Bio trades on the Nasdaq under the ticker CLYM. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 632 million dollars.
What is the ticker symbol for Climb Bio?
Climb Bio trades under the ticker CLYM on the Nasdaq.
What is Climb Bio's market cap?
Climb Bio is a small cap stock with a market cap of about 632 million dollars.
How does Climb Bio make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CLYM stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CLYM stock every day?
Add CLYM to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.